Evozyne
Agent39 out of 100, Below median. Agent Readiness. Open the scores section.Agent Readiness: 39/100. Below median. Measured by StartupHub.ai. Median 41.Trust80 out of 100, Top 25%. Data Trust. Open the scores section.Data Trust: 80/100. Top 25%. Measured by StartupHub.ai. Median 61.AI-driven biotech company engineering novel proteins for therapeutics and sustainability.
About
Evozyne designs novel therapeutic proteins using generative AI to address challenges in immune-mediated diseases. Their AI-native platform, EvoGen, creates new protein mechanisms optimized for potency, stability, and specificity, which are then built and tested in their EvoLab facility. Evozyne translates these engineered proteins into their pipeline for immune therapies, serving patients with high unmet needs where current treatments fail.
Similar companies
AI research lab developing frontier models for protein design and biological discovery.
Shares AI, Biotechnology
Nimbus Therapeutics is a clinical-stage biotech company using computational drug discovery to develop small molecule medicines.
Shares Biotechnology, Drug Discovery
AI biologist platform accelerating preclinical drug development by integrating biological data for smarter decisions.
Shares Biotechnology, Drug Discovery
AI platform for engineering molecular glues to create a new class of medicines.
Shares Biotechnology, Drug Discovery
AI-guided drug discovery platform for tissue-targeted medicines.
Shares Drug Discovery, Protein Engineering
Biotechnology company developing novel protein-based antimicrobial therapeutics.
Shares Biotechnology, Drug Discovery
Key facts
- Website
- evozyne.com
- Headquarters
- Chicago, United States
- Founded
- 2020
- Employees
- 54
- Total funding
- $135M (Series B)
- Business model
- B2B
Funding rounds
| Date | Round | Amount | Lead investors |
|---|---|---|---|
| 27 Sept 2023 | Series B | $81M | OrbiMed, Fidelity Investments |
| 21 Apr 2021 | Series A | $54M |
Tech stack
Detected on evozyne.com, last scanned 30 Oct 2026. Run your own scan
- Frontend
- jQuery
- Analytics
- Google Analytics 4
- CMS / Builders
- WordPress
- CDN
- Cloudflare
- Email provider
- Mimecast
Test your Ahrefs DR
The backlink strength of a domain, on the Ahrefs 0 to 100 scale. About a minute.
Frequently asked
Is Evozyne trustworthy and reputable?
StartupHub's Data Trust & Reputation score for Evozyne is 80 out of 100, a trusted rating, based on site security posture, privacy practices, malware and phishing checks, and public reputation signals.
How much funding has Evozyne raised?
Evozyne has raised a total of $135M in funding. The most recent round on record is Series B.
How many employees does Evozyne have?
Evozyne has approximately 54 people on record.
SEC filings, insider activity, nonprofit links and pay benchmarks for Evozyne:
Company details: from public sources. Funding: no announced round on file. Ownership: not yet claimed by the company. Scores: measured by named tools; each links to its method. Our rules
